AtrionNASDAQ: ATRI

NEW YORK , July 3, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

Discover why Zacks gives Atrion a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Uncover ATRI's impressive growth in the medical devices market and strong financials, alongside challenges like stiff competition in the medical devices market.

NEW YORK , May 28, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Atrion Corporation (NASDAQ: ATRI) and its board of directors concerning the proposed acquisition of the company by Nordson Corporation. Stockholders will receive $460 for each share of Atrion stock that they hold.

MILWAUKEE , May 28, 2024 /PRNewswire/ -- Ademi LLP is investigating Atrion (Nasdaq: ATRI) for possible breaches of fiduciary duty and other violations of law in its transaction Nordson. Click here to learn how to join the https://www.ademilaw.com/case/atrion-corporation or call Guri Ademi toll-free at 866-264-3995.

ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion's 2023 EBITDA, and the $460 per share price represents a 15% premium to Atrion's 90-day average daily volume-weighted average stock price.

ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024.

Atrion Corporation's share price has fallen significantly since the summer due to declining operating performance and inventory issues. The company manufactures niche medical products and has seen modest revenue growth in recent years. Despite the current challenges, the stock is trading at a more reasonable valuation, but more information is needed to assess the nature of the issues.

The article provides insights on upcoming dividend increases, indicating strong business performance and commitment to rewarding shareholders. The list includes companies with at least five years of consistent dividend growth and higher total dividends paid out each year. The article also includes tables and metrics to help investors prioritize stocks based on yield, growth rates, and historical returns.